Further experiments on HCC1143 cells demonstrated that EGF-mediated increases in MAPK activation reduced basal STAT3 activation in a MEK dependent manner, strengthening the connection between MAPK signaling and STAT3 activation in human breast cancer cell lines [Figure 7B]. This evidence concerns the gene MAP2K7 and breast carcinoma.